Optimizing chemotherapy protocol for diverse patient populations

Abstract

Chemotherapy optimization for diverse patient populations is a complex and challenging task that requires a multidisciplinary and individualized approach . Oncology professionals need to be aware of the factors that can affect the response and toxicity of chemotherapy drugs in different patient populations and apply the best available evidence and practices to tailor chemotherapy regimens accordingly. Further research is needed to identify more pharmacogenetic biomarkers, develop more accurate dosing formulas, evaluate more drug interactions, and compare more toxicity profiles for chemotherapy optimization for diverse patient populations.